Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Alves (Vila Nova de Gaia , Portugal), I. Sucena (Vila Nova de Gaia , Portugal), M. Dias (Vila Nova de Gaia , Portugal), D. Coutinho (Vila Nova de Gaia , Portugal), E. Silva (Vila Nova de Gaia , Portugal), T. Costa (Vila Nova de Gaia , Portugal), S. Conde (Vila Nova de Gaia , Portugal), A. Barroso (Vila Nova de Gaia , Portugal), S. Campainha (Vila Nova de Gaia , Portugal). Eosinophilia in lung cancer patients treated with immunotherapy. 4664

Member's Comments

No comment yet.

Related content which might interest you: Re-challenge of immunotherapy in a lung cancer patient Source: Virtual Congress 2021 – Lung cancer grand round Year: 2021 Impact of antibiotics on immunotherapy response in lung cancer patients Source: International Congress 2019 – Treatment of lung cancer Year: 2019 Mianserin therapy in advanced lung cancer patients Source: Eur Respir J 2002; 20: Suppl. 38, 367s Year: 2002 Second-line treatment patients at relapse of disseminated small cell lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 395s Year: 2001 Boosting immunotherapy in lung cancer  Source: International Congress 2017 – ME9 Boosting immunotherapy in lung cancer Year: 2017 Who should treat lung cancer patients and where should they be treated? Source: Annual Congress 2009 - Fitness for radical therapy in lung cancer patients Year: 2009 Second-line therapy in elderly patients with advanced nonsmall cell lung cancer Source: Eur Respir J 2014; 43: 240-249 Year: 2004 How to treat lung cancer in IPF patients Source: Research Seminar 2015 Year: 2015 Impact of COPD on prognosis of lung cancer: the prespective of immunotherapy treatment Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021 Lung cancer immunotherapy Source: International Congress 2018 – Imminent global problems in lung cancer require joint action: time for an international alliance! Year: 2018 Significance of febrile episode in patients with lung cancer during therapy - comparison of NSCLC and SCLC patients Source: Eur Respir J 2002; 20: Suppl. 38, 356s Year: 2002 Neutropenia in lung cancer cases after chemotherapy Source: Eur Respir J 2006; 28: Suppl. 50, 753s Year: 2006 Pecularities of lung cancer in patients with COPD Source: Annual Congress 2011 - Epidemiology of lung cancer and screening Year: 2011 Management of concomitant COPD in patients with lung cancer Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018 Dealys in the diagnosis and treatment of lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 458s Year: 2004 Clinical characteristic of lung cancer patients with interstitial pneumonia treated with chemotherapy or radiotherapy Source: Annual Congress 2008 - Therapy of thoracic tumours Year: 2008 Temozolomide in the treatment of brain metastases in lung cancer patients Source: Eur Respir J 2003; 22: Suppl. 45, 65s Year: 2003 The evaluation of lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 323s Year: 2005 Coexistence of COPD in lung cancer patients Source: Eur Respir J 2001; 18: Suppl. 33, 66s Year: 2001 Early complications after lung resections at patients treated for lung cancer with and without neoadjuvant hemiotheraphy Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011